India’s drug regulator has intensified surveillance of the supply chain of GLP-1 drugs, used for treating type 2 diabetes and obesity, amid growing concerns over their misuse and unauthorized sale.
Hornbill TV
2026-03-24 13:12:54
CDSCO has issued an advisory to pharmaceutical manufacturers, importers, and marketing authorisation holders to ensure strict compliance with the provisions of the Drugs and Cosmetics Act, 1940.
Admin
2026-03-12 13:10:21
Be the first to receive special offers and the latest news.